Influenza Vaccines Among Adults 18+: A New Era of Flu Vaccines for Grown-ups

Tuesday, October 18, 2022
8:00 p.m. to 9:00 p.m. NST

  • Curtis Chafe, B.Sc. Pharm, pharmD, CTH®


Learning Objectives:

  • Provide an overview of influenza specifically elaborating on burden of disease and broader impacts
  • Identify challenges in developing an influenza vaccine
  • Review current influenza vaccine manufacturing technologies
  • Review the latest vaccine and first recombinant vaccine to enter the Canadian market
  • Highlight influenza vaccine recommendations from various public health and assorted agencies